Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala.

Behrens, RH; Cramer, JP; Jelinek, T; Shaw, H; von Sonnenburg, F; Wilbraham, D; Weinke, T; Bell, DJ; Asturias, E; Pauwells, HL; +7 more... Maxwell, R; Paredes-Paredes, M; Glenn, GM; Dewasthaly, S; Stablein, DM; Jiang, ZD; Dupont, HL; (2013) Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala. The Lancet infectious diseases. ISSN 1473-3099 DOI: https://doi.org/10.1016/S1473-3099(13)70297-4

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/S1473-3099(13)70297-4

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar